Enforcement record
Administrative Guidance disclosure naming 臨床薬理協会（臨薬協）
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Administrative Guidance
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
1 September 2024
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
- Captured: Apr 27, 2026, 09:02 AM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Available sources and saved files are listed in the public documents section below.
Public documents and saved materials
View the original publications, see what was preserved, or download each file below.
Loading materials…
Action summary
- Company
- 臨床薬理協会（臨薬協）Japanese onlyOriginal: 臨床薬理協会（臨薬協）
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- Administrative Guidance行政指導
- Action date
- 1 September 2024
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 臨床試験・規制調和
Violation
Reviewing the scope of adverse event reporting in clinical trials, promoting international joint clinical trials, improving the reliability of registries, coordinating GCP inspections internationally, harmonizing regulations, promoting electronic submissions and digitization, and implementing work style reforms and IT system adoption.
Show original Japanese text
治験不具合報告範囲の見直し、国際共同治験の推進、レジストリの信頼性向上、GCP調査の国際調整、規制の国際整合、電子申請・電子化推進、働き方改革とITシステムの導入。
Compliance context
Low-mediumAdministrative guidance or supervision was publicly disclosed by the authority.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Use as a monitoring signal. Confirm details before treating it as a formal sanction.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.